Gastrointestinal manifestations after Roux-en-Y gastric bypass surgery in individuals with and without type 2 diabetes

Roux-en-Y gastric bypass (RYGB) surgery is an effective treatment for obesity, which improves cardiovascular health and reduces risk of premature mortality. However, some reports have suggested that RYGB may predispose to adverse health outcomes such as increased risk of inflammatory bowel disease (IBD) and colorectal cancer.

Source: Surgery for Obesity and Related Diseases - October 21, 2020 Category: Surgery Authors: Mari-Anne H ärma, Krishna Adeshara, Natalie Istomin, Markku Lehto, Michael Blaut, Markku J. Savolainen, Sohvi Hörkkö, Per-Henrik Groop, Vesa Koivukangas, Janne Hukkanen Tags: Original articles Source Type: research